Literature DB >> 2388713

Amino-terminal sequences of a novel heparin-binding protein from human, bovine, rat, and chick brain: high interspecies homology.

D Huber1, P Gautschi-Sova, P Böhlen.   

Abstract

Recently, the partial structural characterization of a novel bovine brain protein was reported (1). Because of its mitogenic activity for vascular endothelial cells and its ability to strongly bind heparin it was termed heparin-binding brain mitogen (HBBM). Although HBBM shares these properties with members of the fibroblast growth factor (FGF) family of growth factors, its amino-terminal sequence is not homologous to that of the FGFs. Now, we report the isolation and partial structural characterization of HBBMs from human, rat and chick brain. Proteins were isolated by tissue extraction at pH 4.5, ammonium sulfate precipitation, cation exchange chromatography, heparin-Sepharose affinity chromatography and reverse-phase HPLC. The amino-terminal sequences of the HBBMs from human, bovine and rat brain are identical, whereas that of chick HBBM reveals a single amino acid substitution. The high sequence homology among the HBBMs from different species suggests an important biological role of the protein.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2388713     DOI: 10.1007/bf00969930

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  18 in total

1.  Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor.

Authors:  F Ishikawa; K Miyazono; U Hellman; H Drexler; C Wernstedt; K Hagiwara; K Usuki; F Takaku; W Risau; C H Heldin
Journal:  Nature       Date:  1989-04-13       Impact factor: 49.962

2.  The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors.

Authors:  X Zhan; B Bates; X G Hu; M Goldfarb
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Potential oncogene product related to growth factors.

Authors:  C Dickson; G Peters
Journal:  Nature       Date:  1987 Apr 30-May 6       Impact factor: 49.962

5.  Isolation and partial molecular characterization of pituitary fibroblast growth factor.

Authors:  P Böhlen; A Baird; F Esch; N Ling; D Gospodarowicz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

6.  Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.

Authors:  N Ferrara; W J Henzel
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

7.  Partial molecular characterization of endothelial cell mitogens from human brain: acidic and basic fibroblast growth factors.

Authors:  P Gautschi; M Fràter-Schröder; P Böhlen
Journal:  FEBS Lett       Date:  1986-08-18       Impact factor: 4.124

8.  An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family.

Authors:  P Delli Bovi; A M Curatola; F G Kern; A Greco; M Ittmann; C Basilico
Journal:  Cell       Date:  1987-08-28       Impact factor: 41.582

9.  Isolation of pituitary fibroblast growth factor by fast protein liquid chromatography (FPLC): partial chemical and biological characterization.

Authors:  D Gospodarowicz; S Massoglia; J Cheng; G M Lui; P Böhlen
Journal:  J Cell Physiol       Date:  1985-02       Impact factor: 6.384

10.  Endothelial cell growth factors in embryonic and adult chick brain are related to human acidic fibroblast growth factor.

Authors:  W Risau; P Gautschi-Sova; P Böhlen
Journal:  EMBO J       Date:  1988-04       Impact factor: 11.598

View more
  3 in total

Review 1.  Molecular and pharmacologic targeting of angiogenesis factors--the example of pleiotrophin.

Authors:  F Czubayko; A M Schulte; S C Missner; S S Hsieh; K J Colley; A Wellstein
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

Review 2.  The potential role of the heparin-binding growth factor pleiotrophin in breast cancer.

Authors:  A T Riegel; A Wellstein
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 3.  Growth factor targeted and conventional therapy of breast cancer.

Authors:  A Wellstein
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.